TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
3 hedge funds and large institutions have $332K invested in TITAN PHARMACEUTICAL INC in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
12% more capital invested
Capital invested by funds: $297K → $332K (+$35.1K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$2.76K |
Top Sellers
TTP Hedge Fund Activity: Q1 2014 in Review
3 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q1 2014, worth a combined $332K — up 12% from $297K a quarter earlier.
Fund positioning in TTP was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Gagnon Securities, adding an estimated $2.76K.
- 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $332K of TITAN PHARMACEUTICAL INC stock for Q1 2014, up 12% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q1 2014 and 0 closed out.
- The largest TITAN PHARMACEUTICAL INC buyer in Q1 2014 was Gagnon Securities, an estimated $2.76K added.
Based on aggregated 13F filings for Q1 2014.